Business, energy, technology, markets and global industry news from Business News Today

European Academy of Allergy and Clinical Immunology

PharmaDeviceNews European Academy of Allergy and Clinical Immunology
Representative image: OM Pharma’s Broncho-Vaxom OM-85 real-world evidence study highlights growing clinical interest in respiratory tract infection prevention, non-antibiotic care strategies, and data-driven respiratory health research.
Pharma & Biotech

Could OM Pharma’s Broncho-Vaxom study change how clinicians assess recurrent RTI prevention?

Find out how OM Pharma’s Broncho-Vaxom data could reshape RTI prevention, real-world evidence and non-antibiotic care strategies.

Read More
Pharma & Biotech

Why Intellia’s lonvo-z Phase 3 data could raise expectations for one-time HAE treatment

Find out how Intellia’s lonvo-z Phase 3 data could change expectations for one-time hereditary angioedema treatment.

Read More